251 related articles for article (PubMed ID: 15454089)
21. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
22. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
23. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
[TBL] [Abstract][Full Text] [Related]
24. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
25. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
[TBL] [Abstract][Full Text] [Related]
26. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
Petryk A; Shimmi O; Jia X; Carlson AE; Tervonen L; Jarcho MP; O'connor MB; Gopalakrishnan R
Bone; 2005 Apr; 36(4):617-26. PubMed ID: 15780974
[TBL] [Abstract][Full Text] [Related]
27. Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element.
Yu L; van der Valk M; Cao J; Han CY; Juan T; Bass MB; Deshpande C; Damore MA; Stanton R; Babij P
Bone; 2011 Dec; 49(6):1131-40. PubMed ID: 21890009
[TBL] [Abstract][Full Text] [Related]
28. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
29. Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.
Ideno H; Takanabe R; Shimada A; Imaizumi K; Araki R; Abe M; Nifuji A
Exp Cell Res; 2009 Feb; 315(3):474-84. PubMed ID: 19073177
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
Bellido T
J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
[No Abstract] [Full Text] [Related]
31. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
34. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
35. BMP and BMP inhibitors in bone.
Rosen V
Ann N Y Acad Sci; 2006 Apr; 1068():19-25. PubMed ID: 16831902
[TBL] [Abstract][Full Text] [Related]
36. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
Zachos TA; Shields KM; Bertone AL
J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7.
Yang M; Ma QJ; Dang GT; Ma Kt; Chen P; Zhou CY
Cytotherapy; 2005; 7(3):273-81. PubMed ID: 16081354
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
[TBL] [Abstract][Full Text] [Related]
39. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
40. The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells.
Kósa JP; Kis A; Bácsi K; Balla B; Nagy Z; Takács I; Speer G; Lakatos P
Bone; 2011 May; 48(5):1052-7. PubMed ID: 21277400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
